We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A hand holding an Eppendorf tube with the letters representing DNA bases in the background.
Product News

Mayo Clinic and Oxford Nanopore Announce Collaboration

Joint development collaboration to bring leading-edge nanopore sequencing into clinical laboratories at Mayo Clinic to increase understanding and improve treatment of cancer and genetic disorders.
Cancer cells.
Product News

CELLINK & Carcinotech Partner to Personalize Cancer Drug Development

Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models.
A scientist holding a rack of blood samples.
Product News

Sebia Launches M-InSight®, a Test for Monitoring Multiple Myeloma Patients

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma.
Representation of human cells.
Product News

Curiox Biosystems To Advance Next-Generation Cancer Cell Therapies Through Collaboration With Leading Cancer Researcher

Curiox Biosystems announces its collaboration with Dr. Marco Ruella, an assistant professor of medicine at the Perelman School of Medicine, to support efforts in the development of next-generation cancer cell therapies.
Cancer cells.
Product News

Orano Med and Orbit Discovery Enter Collaboration To Discover Novel Targeted Radioligand Therapies for Cancer

Orano Med SAS, and Orbit Discovery Ltd, announced that they have entered into a collaboration to discover specific Peptide Receptor Radionuclide Therapies against cancer cells and advance the development of novel radiopharmaceuticals.
Immunohistochemistry on a human breast cancer tissue microarray.
Product News

Custom Monoclonal Antibody Reveals Promising HER2+ Breast Cancer Target

AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development.
A screengrab from the Alpha portal.
Product News

A New Portal To Ef-FIT-ciency

Introducing The Alpha Portal (TAP) by Alpha Laboratories.
The cytiva logo
Product News

Cytiva Launches System To Enable End-to-End Manufacturing of Lipid Nanoparticle Medicines

Cytiva has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines.
Various types of oral medication on a yellow background.
Product News

Landmark Study Demonstrates Economic Edge of Precision Medicine

A landmark study demonstrates that precision oncology medicines could deliver a superior return on Investment for Pharma R&D vs their one size fits all counterparts.
Two medical professionals looking at a computer screen.
Product News

Oncodesign Services Announce Access to ImaginAb’s CD8 ImmunoPET™ Technology

Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc. for the use of their investigational CD8 ImmunoPET™ (89Zr crefmirlimab berdoxam) technology.
Advertisement